Pyridostigmine or calymin

Kalymin 60 N is an effective medicine for the treatment of myasthenia gravis, a chronic neuromuscular disease that leads to muscle weakness and fatigue. The medicine contains the active ingredient pyridostigmine, a cholinesterase inhibitor that improves the transmission of signals between nerves and muscles in order to stabilise muscle function and alleviate symptoms. Kalymin 60 N is available in film-coated tablet form and is suitable for the long-term treatment of this condition.

Technical description

• Active substance: pyridostigmine bromide (60 mg per film-coated tablet)
• Film-coated tablet
• Treatment of myasthenia gravis and myasthenic syndrome
• Inhibition of acetylcholinesterase to improve neuromuscular signalling
• 100 film-coated tablets

Article number Kalymin:

MED-60-KALYMIN